News

The BSE Sensex dropped 823.16 points, or 1.00%, to close at 81,691.98, while the NSE Nifty fell 253.20 points, or 1.01%, to close at 24,888.20. The market capitalisation of all listed companies on ...
One of the market’s sharpest moves came from Warner Bros. Discovery, which jumped 11.8% after saying it would split into two companies. One will get Warner Bros. Television, HBO Max and other studio ...
In One Chart Megacap stocks aren’t all up in 2025. But this chart shows they’ve trounced the S&P 500’s smallest equities. ‘While there may have been some concerns over the performance of ...
It’s described by the developer as a “powerful all-in-one Windows maintenance toolkit” designed “for power users, system administrators, and curious tinkerers.” Besides those tools, it ...
The Nobl All-in-One Carry-On suitcase offers hands-free travel with convenient features. It includes 360-degree wheels, a built-in phone holder, and a cup holder.
- Shares of UnitedHealth have been pummeled in 2025, dragging down the Dow Jones Industrial Average. - The Dow remains an interesting gauge of large-cap U.S. companies.
German biotech firm BioNTech has agreed to acquire domestic peer CureVac for about $1.25 billion worth of BioNTech shares, it said on Thursday, to boost its work on new mRNA-based cancer treatments.
What the chart says may come next. The stock has suffered its longest losing streak in years, and just fell below a closely watched chart level, but there’s still no technical reason for bulls ...
BioNTech is buying fellow German mRNA vaccine developer CureVac in an all-stock transaction that values the acquired biotech at $1.25 billion. The announcement makes no specific mention of ...